Bloomberg Law
Pharma & Life Sciences
LinkedIn

Alkermes Sues Teva Over ANDA for Generic Version of Vivitrol

Sept. 9, 2020, 9:06 PM UTC
Greg Chang
Greg Chang
Bloomberg News

Alkermes said it sued Teva Pharmaceuticals USA in U.S. district court over Teva’s Abbreviated New Drug Application for a generic version of Vivitrol.

  • The filing of the lawsuit triggered a stay of FDA approval of the application for up to 30 months

To view the source of this information click here

To contact the reporter on this story:
Greg Chang in San Francisco at gchang1@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.